Oncomatryx Biopharma SL:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Oncomatryx Biopharma SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11186
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Oncomatryx Biopharma SL (Oncomatryx) is a developer of precision drugs. The company offers precision drugs that targets proteins located in the tumor environment. It develops therapeutic antibody-drug conjugates, antibodies, and human-derived proteins, which targets tumor associated stroma. Oncomatryx’s products comprise DMTX invaScan, DMTX bladderScan, DMTX breastScan, and companion diagnostics, among others. The company offers sensitive and specific monoclonal antibodies for the diagnosis of invasive carcinomas, among others. It markets its products through a network of distributors in Spain and abroad. Oncomatryx is headquartered in Derio, Spain.

Oncomatryx Biopharma SL – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Oncomatryx Biopharma SL, Medical Devices Deals, 2012 to YTD 2018 9
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Oncomatrix Enters Into Co-Development Agreement With University Of Stuttgart For Tumor Metastases Drugs 11
Licensing Agreements 12
Oncomatrix Enters Into Licensing Agreement With National Jewish Health For Cystatin-C Intellectual Property 12
Equity Offering 13
Oncomatryx Biopharma Raises USD5 Million in Equity Financing 13
Oncomatryx Biopharma SL – Key Competitors 14
Oncomatryx Biopharma SL – Key Employees 15
Oncomatryx Biopharma SL – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Key Facts 2
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Oncomatryx Biopharma SL, Deals By Therapy Area, 2012 to YTD 2018 8
Oncomatryx Biopharma SL, Medical Devices Deals, 2012 to YTD 2018 9
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Oncomatrix Enters Into Co-Development Agreement With University Of Stuttgart For Tumor Metastases Drugs 11
Oncomatrix Enters Into Licensing Agreement With National Jewish Health For Cystatin-C Intellectual Property 12
Oncomatryx Biopharma Raises USD5 Million in Equity Financing 13
Oncomatryx Biopharma SL, Key Competitors 14
Oncomatryx Biopharma SL, Key Employees 15

List of Figures
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Oncomatryx Biopharma SL, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Oncomatryx Biopharma SL:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • China Sunergy Co., Ltd. (CSUNY):電力:M&Aディール及び事業提携情報
    Summary China Sunergy Co., Ltd. (China Sunergy) is a leading manufacturer of solar cells and modules. It produces mono-crystalline and multi-crystalline silicon solar cells. The company offers standard P-type solar cells and HP solar cells; and selective emitter cells. China Sunergy also invests in, …
  • Southern Research Institute-製薬・医療分野:企業M&A・提携分析
    Summary Southern Research Institute (Southern Research) is a contract research organization which conducts research in the areas of advanced engineering, preclinical drug development, drug discovery and environmental protection. Its life science services include preclinical drug development, basic r …
  • BBB Technologies Inc:製品パイプライン分析
    Summary BBB Technologies Inc (BBB Tech) is a development stage medical technology company, which develops devices and applications that facilitate the early diagnosis of metabolic and cardiovascular disorders. It develops single-drop, mobile integrated diagnostic tools for blood testing. Its lead pr …
  • Jackson Electric Membership Corporation:企業の戦略的SWOT分析
    Jackson Electric Membership Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Sihayo Gold Ltd:企業の戦略・SWOT・財務分析
    Sihayo Gold Ltd - Strategy, SWOT and Corporate Finance Report Summary Sihayo Gold Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • American CryoStem Corp (CRYO):医療機器:M&Aディール及び事業提携情報
    Summary American CryoStem Corp (American CryoStem), formerly Advanced Wound Technologies-MidAtlantic LLC is a manufacturer, developer, and marketer of life-enhancing and stem cell technologies. The company offers products such as adipose derived stem cells, tissue collection and transportation produ …
  • Bumi Armada Bhd (ARMADA):企業の財務・戦略的SWOT分析
    Bumi Armada Bhd (ARMADA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Sherwin-Williams Co (SHW):企業の財務・戦略的SWOT分析
    Sherwin-Williams Co (SHW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Edwards Lifesciences Corporation:企業のM&A・事業提携・投資動向
    Edwards Lifesciences Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Edwards Lifesciences Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • Neurones SA (NRO):企業の財務・戦略的SWOT分析
    Neurones SA (NRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Societatea Nationala Nuclearelectrica SA (SNN):企業の財務・戦略的SWOT分析
    Societatea Nationala Nuclearelectrica SA (SNN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Fred’s Inc:企業の戦略・SWOT・財務情報
    Fred's Inc - Strategy, SWOT and Corporate Finance Report Summary Fred's Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Klepierre SA:企業のM&A・事業提携・投資動向
    Klepierre SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Klepierre SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Veeco Instruments Inc (VECO):企業の財務・戦略的SWOT分析
    Summary Veeco Instruments Inc (Veeco) is a technology company that designs, manufacture and markets thin film and semiconductor equipment. The company offers various products and technologies which include MOCVD systems, precision surface processing system, MBE technologies, and ion beam sputtering. …
  • Alliance Data Systems Corp (ADS):企業の財務・戦略的SWOT分析
    Alliance Data Systems Corp (ADS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • The Real Good Food Company plc:戦略・SWOT・企業財務分析
    The Real Good Food Company plc - Strategy, SWOT and Corporate Finance Report Summary The Real Good Food Company plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Franklin Covey Co. (FC):企業の財務・戦略的SWOT分析
    Franklin Covey Co. (FC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Witte Molen NV:企業の戦略・SWOT・財務分析
    Witte Molen NV - Strategy, SWOT and Corporate Finance Report Summary Witte Molen NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Koninklijke Philips N.V. (PHIA)-製薬・医療分野:企業M&A・提携分析
    Summary Koninklijke Philips N.V. (Philips) is a diversified technology company which focuses on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. The company develops and manufactures medical …
  • M. A. Mortenson Co:戦略・SWOT・企業財務分析
    M. A. Mortenson Co - Strategy, SWOT and Corporate Finance Report Summary M. A. Mortenson Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆